Cancer Gene Therapy Market Outlook 2025-2032: Witness Booming Growth, Demand, and Market Share | Biogen (U.S.), Sarepta Therapeutics Inc. (U.S.), Gilead Science Inc. (U.S.)

The global cancer gene therapy Market size was valued at USD 2.28 billion in 2024 and is projected to reach USD 4.79 billion by 2032, with a CAGR of 9.70% during the forecast 2025 to 2032.

𝐓𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐫𝐞𝐬𝐮𝐥𝐭 𝐨𝐟 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐛𝐲 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 𝐨𝐟 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 -

• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies

Coverage of the Cancer Gene Therapy Market:

The report provides 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 (𝟐𝟎𝟐𝟎 - 𝟐𝟎𝟑𝟐) 𝐕𝐚𝐥𝐮𝐞 (𝐔𝐒$ 𝐌𝐧), 𝐘-𝐨-𝐘 % 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞, and 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 (𝟐𝟎𝟐𝟓 - 𝟐𝟎𝟑𝟐), CAGR % for all the segments and sub segments wherein:

⦿ 𝟐𝟎𝟐𝟎-𝟐𝟎𝟐𝟑: 𝐇𝐢𝐬𝐭𝐨𝐫𝐢𝐜 𝐘𝐞𝐚𝐫,
⦿ 𝟐𝟎𝟐𝟒: 𝐁𝐚𝐬𝐞 𝐘𝐞𝐚𝐫,
⦿ 𝟐𝟎𝟐𝟓: 𝐄𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐘𝐞𝐚𝐫,
⦿ 𝟐𝟎𝟐𝟓 𝐭𝐨 𝟐𝟎𝟑𝟐: 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐏𝐞𝐫𝐢𝐨𝐝.

👉 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝟕𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭: @ : https://www.coherentmarketinsights.com/promo/buynow/103024

𝐓𝐡𝐞 𝐥𝐚𝐭𝐞𝐬𝐭 𝐯𝐞𝐫𝐬𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 (𝐕𝐞𝐫𝐬𝐢𝐨𝐧 𝟐𝟎𝟐𝟓) 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐯𝐚𝐫𝐢𝐨𝐮𝐬 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐦𝐞𝐭𝐫𝐢𝐜𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

• Bulls Eye Analysis
• Coherent Opportunity Map
• Wheel of Fortune
• Market Attractive Analysis, by Product Type
• Market Attractive Analysis, by Country
• Pestle Analysis
• 4 Ps (Product, Price, Place, and Promotion)
• Porters Analysis
• SWOT Analysis
• Competitive Landscape
• Company Market Share Analysis (US$ Mn)

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐜𝐥𝐚𝐬𝐬𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭:

❖By Therapy: Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer
❖By End Users: Hospitals, Oncology Institutes, Biotechnological Companies, Clinical Research Laboratories

𝐓𝐡𝐞 𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐫𝐞:

•Biogen (U.S.)
• Sarepta Therapeutics Inc. (U.S.)
• Gilead Science Inc. (U.S.)
• AmgenInc. (U.S.)
• Novartis AG (Switzerland)
• Orchard Therapeutics Plc (U.K.)
• Spark TherapeuticsInc. (U.S.)
• AGC Biologics (U.S.)
• AngesInc. (Japan)
• Bluebird BioInc. (U.S.)
• Jazz Pharmaceuticals Inc. (Ireland)
• Dynavax Technologies (U.S.)
• Human Stem Cells Institute (Russia)
• Sibiono (China)
• Shanghai Sunway Biotech Co.Ltd. (China)
• Uniqure N.V. (Netherlands)
• Gensight Biologics (France)
• Celgene Corporation (U.S.)
• Cellectis (France)

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 - https://www.coherentmarketresearch.com/samplepages/103024

✦ 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:

➡ Rising Incidence of Cancer: The global increase in cancer cases is a primary driver of market growth. As cancer remains one of the leading causes of death worldwide, there is a pressing need for innovative treatment options, including gene therapy. This trend is expected to continue as the World Health Organization projects that cancer cases will rise significantly in the coming years.

➡ Advancements in Gene Technologies: Continuous improvements in genetic engineering techniques are facilitating the development of more effective and targeted gene therapies. Innovations such as CRISPR and other gene-editing technologies are enabling researchers to create therapies that can precisely target cancer cells while minimizing damage to healthy tissues.

➡ Growing Demand for Personalized Medicine: There is an increasing shift towards personalized treatment approaches in oncology, with gene therapies being tailored to individual patient profiles based on genetic makeup. This trend is enhancing treatment efficacy and improving patient outcomes, driving demand for customized gene therapies.

➡ Increased Investment in Research and Development: Substantial funding from both public and private sectors is being directed towards R&D in cancer gene therapy. This investment is crucial for advancing clinical trials and bringing new therapies to market more quickly. Companies are focusing on developing combination therapies that leverage the strengths of multiple treatment modalities.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐩𝐫𝐨𝐜𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬:

⏩ This study offers a thorough analysis of current trends, forecasts, and market size dynamics in the Cancer Gene Therapy Market from 2025 to 2032, helping to pinpoint the most promising opportunities.
⏩ Porter's Five Forces analysis highlights the influence of buyers and suppliers, empowering stakeholders to make informed business decisions and enhance their supplier-buyer networks.
⏩ Comprehensive research on market size and segmentation enables the identification of existing opportunities within the Cancer Gene Therapy Market.
⏩ The report maps out the leading countries in each region based on their contribution to market revenue.
⏩ An extensive analysis of the top competitors in the Cancer Gene Therapy Market is provided, offering valuable insights into the competitive landscape.

𝐑𝐞𝐚𝐬𝐨𝐧𝐬 𝐭𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:

👉 Strategic Competitor Insights: Gain critical information and analysis on key competitors to develop effective sales and marketing strategies.
👉 Identify Emerging Players: Discover new entrants with promising product portfolios and formulate counter-strategies to enhance your competitive edge.
👉 Target Client Identification: Classify potential new clients or partners within your target demographic for better market penetration.
👉 Tactical Initiative Development: Understand the focal areas of leading companies to craft informed tactical initiatives.
👉Mergers and Acquisitions Planning: Make strategic decisions regarding mergers and acquisitions by pinpointing top manufacturers in the market.
👉Licensing Strategy Development: Identify prospective partners with attractive projects to create robust in-licensing and out-licensing strategies, thereby enhancing business potential.
👉Support for Presentations: Utilize reliable, high-quality data and analysis to strengthen your internal and external presentations.

This report provides actionable growth insights through a comprehensive analysis that includes secondary research, primary interviews with industry stakeholders and competitors, and validation and triangulation using the Coherent Market Insights regional database. Experts have meticulously compiled primary data from market participants across the value chain in all regions and insights from industry specialists to deliver qualitative and quantitative findings.

👉 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝟕𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭:@ : https://www.coherentmarketinsights.com/promo/buynow/103024

𝐅𝐀𝐐'𝐬

Q.1 What are the main factors influencing the Cancer Gene Therapy market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market's opportunities, risks, and general structure?
Q.4 Which of the top Cancer Gene Therapy Market companies compare in terms of sales, revenue, and prices?
Q.5 How are market types, applications, deals, revenue, and value explored?
Q.6 What does a business area's assessment of agreements, income, and value implicate?

𝐀𝐮𝐭𝐡𝐨𝐫 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐏𝐑:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, have a sales office at global financial capital in the U.S., and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed to leading in offering insights into various sectors post-COVID-19 and continue delivering measurable, sustainable results for our clients.

☎️ 𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

This release was published on openPR.